Stay updated with breaking news from Nasdaq Cnmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONMED (NASDAQ:CNMD – Get Rating) and ViewRay (NASDAQ:VRAY – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Valuation and Earnings This table compares CONMED and ViewRay’s top-line revenue, earnings […]
CONMED (NASDAQ:CNMD – Get Rating) and Viveve Medical (NASDAQ:VIVE – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Profitability This table compares CONMED and Viveve Medical’s net margins, return […]
CONMED (NASDAQ:CNMD – Get Rating) and Guided Therapeutics (OTCMKTS:GTHP – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, risk, analyst recommendations, valuation and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and price […]
StockNews.com upgraded shares of CONMED (NASDAQ:CNMD – Get Rating) from a sell rating to a hold rating in a research note published on Friday. CONMED Stock Performance CONMED stock opened at $125.85 on Friday. CONMED has a fifty-two week low of $71.09 and a fifty-two week high of $140.21. The stock has a market cap […]
Analysts expect that CONMED Co. (NASDAQ:CNMD – Get Rating) will report $274.75 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for CONMED’s earnings, with the highest sales estimate coming in at $278.10 million and the lowest estimate coming in at $270.53 million. CONMED reported sales of […]